SOBR SAFE INC (SOBR)

US8335922071 - Common Stock

0.96  -0.14 (-12.73%)

After market: 0.9598 0 (-0.02%)

Fundamental Rating

2

Overall SOBR gets a fundamental rating of 2 out of 10. We evaluated SOBR against 127 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of SOBR is average, but there are quite some concerns on its profitability. SOBR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year SOBR has reported negative net income.
SOBR had a negative operating cash flow in the past year.
SOBR had negative earnings in each of the past 5 years.
SOBR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SOBR has a worse Return On Assets (-323.44%) than 99.20% of its industry peers.
SOBR has a Return On Equity of -519.04%. This is amonst the worse of the industry: SOBR underperforms 96.00% of its industry peers.
Industry RankSector Rank
ROA -323.44%
ROE -519.04%
ROIC N/A
ROA(3y)-176.08%
ROA(5y)-292.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SOBR's Gross Margin of 40.15% is fine compared to the rest of the industry. SOBR outperforms 70.40% of its industry peers.
The Profit Margin and Operating Margin are not available for SOBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

SOBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SOBR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SOBR has less shares outstanding
Compared to 1 year ago, SOBR has a worse debt to assets ratio.

2.2 Solvency

SOBR has an Altman-Z score of -47.48. This is a bad value and indicates that SOBR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SOBR (-47.48) is worse than 97.60% of its industry peers.
There is no outstanding debt for SOBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -47.48
ROIC/WACCN/A
WACC16.61%

2.3 Liquidity

SOBR has a Current Ratio of 0.78. This is a bad value and indicates that SOBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SOBR has a worse Current ratio (0.78) than 95.20% of its industry peers.
SOBR has a Quick Ratio of 0.78. This is a bad value and indicates that SOBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SOBR has a worse Quick ratio (0.54) than 94.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.54

1

3. Growth

3.1 Past

The earnings per share for SOBR have decreased strongly by -8305.86% in the last year.
The Revenue has grown by 22.57% in the past year. This is a very strong growth!
EPS 1Y (TTM)-8305.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4754.79%
Revenue 1Y (TTM)22.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%27.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y31.25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SOBR. In the last year negative earnings were reported.
Also next year SOBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SOBR!.
Industry RankSector Rank
Dividend Yield N/A

SOBR SAFE INC

NASDAQ:SOBR (12/20/2024, 8:00:02 PM)

After market: 0.9598 0 (-0.02%)

0.96

-0.14 (-12.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners2.94%
Inst Owner Change10.31%
Ins Owners3.46%
Ins Owner Change0%
Market Cap883.20K
AnalystsN/A
Price TargetN/A
Short Float %7.07%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-94.78%
Min Revenue beat(2)-95.34%
Max Revenue beat(2)-94.23%
Revenue beat(4)0
Avg Revenue beat(4)-94.93%
Min Revenue beat(4)-95.7%
Max Revenue beat(4)-94.23%
Revenue beat(8)0
Avg Revenue beat(8)-94.08%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.8
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-55.48
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-6.66
FCFYN/A
OCF(TTM)-6.66
OCFYN/A
SpS0.2
BVpS2.27
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -323.44%
ROE -519.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.15%
FCFM N/A
ROA(3y)-176.08%
ROA(5y)-292.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.54
Altman-Z -47.48
F-Score3
WACC16.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8305.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4754.79%
EPS Next Y31.25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%27.19%
Revenue Next Year100%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.1%
OCF growth 3YN/A
OCF growth 5YN/A